ArticleJTCVS open2024
Fifteen-year experience of direct bridge with venoarterial extracorporeal membrane oxygenation to heart transplantation.
Article in JTCVS open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The study objective was to evaluate outcomes of patients directly bridged with venoarterial extracorporeal membrane oxygenation to heart transplantation. Methods: A single-center retrospective study was performed on 1152 adult patients undergoing isolated cardiac transplantation between January 2007 and December 2021. Among these, patients bridged with an extracorporeal membrane oxygenation to transplantation (extracorporeal membrane oxygenation group, n = 317) were compared with standard cohorts of patients (no extracorporeal membrane oxygenation group, n = 835). A period analysis (Era 1, 2007-2013, vs Era 2, 2014-2021) was performed. Results: Median duration of extracorporeal membrane oxygenation support before transplantation in the extracorporeal membrane oxygenation group was 8 days. Recipients of extracorporeal membrane oxygenation group were younger, with a better renal function and a shorter time on the waiting list. They were allocated to younger donors, with a longer ischemic time. The extracorporeal membrane oxygenation group and no extracorporeal membrane oxygenation group showed similar 1-year and 9-year survivals: 79.2% versus 79.4%, Conclusions: Extracorporeal membrane oxygenation as a direct bridge to heart transplantation shows similar outcomes to standard cohorts of patients. In the extracorporeal membrane oxygenation group, the waiting list time is shorter due to the emergency allocation system, and recipients have no evidence of organ dysfunction at the time of transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.